Kyushu University
Clinical trials sponsored by Kyushu University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for kids with tough cancers: GAIA-102 trial launches Results expected Aug 2027 (estimated)
-
New hope for kids with tough cancers: GAIA-102 trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug called GAIA-102 in children whose neuroblastoma or other solid tumors have not responded to standard treatments. The study has four groups, testing GAIA-102 alone or combined with other cancer drugs. The main goal is to check safety and fin…
Phase 1 • Sponsor: Kyushu University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers: GAIA-102 trial targets malignant ascites
Disease control Recruiting nowThis clinical trial is testing a new biological therapy called GAIA-102, alone or combined with the immunotherapy pembrolizumab, for people with advanced stomach or pancreatic cancer that has spread and caused fluid buildup in the abdomen (malignant ascites). The study has two pa…
Phase 1/2 • Sponsor: Kyushu University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC